Physiologic estrogen receptor alpha signaling in non-tumorigenic human mammary epithelial cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2006-03-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-006-9177-0PMID 16541319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• STEROIDRECEPTORSANDPROLIFERATIONIN THE HUMANBREAST Results and Discussion Distribution of ER in Normal Human Breast Lobules

  2006cited by this paper
• Characterization of the estrogen receptor transfected MCF10A breast cell line 139B6

  2005cited by this paper
• Protein Phosphatase 2A Regulates Estrogen Receptor α (ER) Expression through Modulation of ER mRNA Stability*

  2005cited by this paper
• K-ras as a target for cancer therapy.

  2005cited by this paper
• Anatomy of the estrogen response element.

  2004cited by this paper
• BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis

  2004cited by this paper
• p21 (WAF1/CIP1) Mediates the Growth Response to TGF-b in Human Epithelial Cells

  2004cited by this paper
• Induction of p21 (CIP1/WAF1/SID1) by estradiol in a breast epithelial cell line transfected with the recombinant estrogen receptor gene:

  2004cited by this paper
• TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression

  2003cited by this paper
• TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

  2003cited by this paper
• Cellular and molecular targets of estrogen in normal human breast tissue.

  2002cited by this paper
• Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.

  2002cited by this paper
• Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line.

  2002cited by this paper
• ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR‐positive cancer cell lines with or without erbB2 overexpression

  2001cited by this paper
• erbB-2 overexpression in human mammary epithelial cells confers growth factor independence.

  1999cited by this paper
• The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines.

  1999cited by this paper
• Growth response of breast epithelial cells to estrogen is influenced by EGF.

  1999cited by this paper
• Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor

  1999influential reference
• Direct action of estrogen on sequence of progression of human preneoplastic breast disease.

  1998cited by this paper
• Environmental estrogen stimulation of growth and estrogen receptor function in preneoplastic and cancerous human breast cell lines.

  1997cited by this paper
• Unliganded Epidermal Growth Factor Receptor Dimerization Induced by Direct Interaction of Quinazolines with the ATP Binding Site*

  1997cited by this paper
• Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15

  1997cited by this paper
• Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.

  1997cited by this paper
• Improved dicistronic mRNA expression vectors for efficient selection of transfectants highly expressing foreign genes.

  1996cited by this paper
• Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.

  1996cited by this paper
• All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired (*)

  1996cited by this paper
• Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522.

  1994cited by this paper
• Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells.

  1994cited by this paper
• Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor.

  1992influential reference
• Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines.

  1990cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.

  1987cited by this paper
• Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue.

  1987cited by this paper
• Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.

  1984cited by this paper

• Inducible estrogen receptor alpha in normal breast epithelial cells demonstrate estrogen receptor-dependent DNA damage

  2025cites this paper
• Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation–Specific and HIF-Dependent Manner

  2020cites this paper
• The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies

  2018cites this paper
• Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor‐negative breast cancer

  2017cites this paper
• Novel Hormonal Combination Therapy for Triple Negative Breast Cancer

  2016cites this paper
• Targeting Histone Abnormality in Triple Negative Breast Cancer

  2015cites this paper
• MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers

  2014cites this paper
• GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast

  2014influential citation
• Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.

  2013cites this paper
• Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.

  2013cites this paper
• Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation

  2013cites this paper
• The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

  2012cites this paper
• Androgen receptor as a targeted therapy for breast cancer.

  2012cites this paper
• Review Article Androgen receptor as a targeted therapy for breast cancer

  2012cites this paper
• Estrogen Receptor α Signaling Regulates Breast Tumor-initiating Cells by Down-regulating miR-140 Which Targets the Transcription Factor SOX2*

  2012cites this paper
• PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells

  2011cites this paper
• Anacardic Acid Inhibits Estrogen Receptor α–DNA Binding and Reduces Target Gene Transcription and Breast Cancer Cell Proliferation

  2010influential citation
• Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

  2010cites this paper
• Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor α to vinblastine and vinorelbine

  2010cites this paper
• Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity.

  2009cites this paper
• Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines

  2009cites this paper
• Tamoxifen-stimulated growth of breast cancer due to p21 loss

  2008cites this paper
• Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.

  2007cites this paper
• Estrogen Receptor α Mediates Breast Cancer Cell Resistance to Paclitaxel through Inhibition of Apoptotic Cell Death

  2007cites this paper
• Silencing estrogen receptor α in breast cancer cells

  2006cites this paper